Farallon Capital Management’s Idexx Laboratories IDXX Stock Holding History

Farallon Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.74M	Buy	+9,000	New	+$5.05M	0.02%	69

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Farallon Capital Management's IDXX Position: Q2 2026 in Review

Farallon Capital Management opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 9,000 shares worth $4.74M. The stake represents 0.02% of the portfolio and ranks #69 among its holdings.

1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Farallon Capital Management held 9,000 shares of Idexx Laboratories worth $4.74M as of Q2 2026.
Idexx Laboratories was a new Farallon Capital Management position in Q2 2026.
Idexx Laboratories made up 0.02% of Farallon Capital Management's portfolio in Q2 2026, its #69 holding.
1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Farallon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.